Cargando…

Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are an important tool in the management of canine osteoarthritis, with the most recent introduction into the category being grapiprant, a piprant that selectively targets the EP4 prostaglandin receptor. To date there have been no efficacy st...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Salazar Alcalá, Andrea García, Gioda, Lucile, Dehman, Alia, Beugnet, Frederic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716846/ https://www.ncbi.nlm.nih.gov/pubmed/31464629 http://dx.doi.org/10.1186/s12917-019-2052-0

Ejemplares similares

Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
por: de Salazar Alcalá, Andrea García, et al.
Publicado: (2019)

Grapiprant: A snapshot of the current knowledge
por: Sartini, Irene, et al.
Publicado: (2021)

Analgesic efficacy of oral firocoxib in ovariohysterectomized cats
por: Phuwapattanachart, Prangtip, et al.
Publicado: (2017)

Cutaneous adverse drug reaction in a dog following firocoxib treatment
por: Geum, Migyeong, et al.
Publicado: (2021)

Use of firocoxib for the treatment of equine osteoarthritis
por: Donnell, Josh R, et al.
Publicado: (2014)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ
por: Heit, Mark C., et al.
Publicado: (2021)

Quantification of Grapiprant and Its Stability Testing under Changing Environmental Conditions
por: Gumułka, Paweł, et al.
Publicado: (2022)

Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses
por: Fadel, Charbel, et al.
Publicado: (2023)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses
por: Araújo, Renatha A., et al.
Publicado: (2023)

Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses
por: White, Julianne M., et al.
Publicado: (2023)

A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis
por: Rausch‐Derra, L., et al.
Publicado: (2016)

The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2019)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Improvement of the Firocoxib Dissolution Performance Using Electrospun Fibers Obtained from Different Polymer/Surfactant Associations
por: Maggi, Lauretta, et al.
Publicado: (2019)

Correction to: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2020)

Performance of a blockwise approach in variable selection using linkage disequilibrium information
por: Dehman, Alia, et al.
Publicado: (2015)

Insecticidal efficacy of afoxolaner against Stomoxys calcitrans (Diptera: Muscidae) in dogs
por: Tielemans, Eric, et al.
Publicado: (2021)

Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment
por: Delsart, Aliénor, et al.
Publicado: (2022)

Afoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogs
por: Beugnet, Frédéric, et al.
Publicado: (2014)

Repellency and acaricidal efficacy of a new combination of fipronil and permethrin against Ixodes ricinus and Rhipicephalus sanguineus ticks on dogs
por: Dumont, Pascal, et al.
Publicado: (2015)

Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Preventive efficacy of NexGard Spectra(®) against Dipylidium caninum infection in dogs using a natural flea (Ctenocephalides felis) infestation model
por: Beugnet, Frédéric, et al.
Publicado: (2017)

Insecticidal efficacy of afoxolaner against bedbugs, Cimex lectularius, when administered orally to dogs
por: Beugnet, Frederic, et al.
Publicado: (2021)

Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area
por: Panarese, Rossella, et al.
Publicado: (2021)

Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions
por: Mihalca, Andrei Daniel, et al.
Publicado: (2022)

Assessment of the efficacy of a topical combination of fipronil-permethrin (Frontline Tri-Act(®)/Frontect(®)) against egg laying and adult emergence of the cat flea (Ctenocephalides felis) in dogs
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Adjacency-constrained hierarchical clustering of a band similarity matrix with application to genomics
por: Ambroise, Christophe, et al.
Publicado: (2019)

Prevention of the transmission of Babesia rossi by Haemaphysalis elliptica in dogs treated with Nexgard(®)
por: Beugnet, Frederic, et al.
Publicado: (2019)

Preventive efficacy of Frontline(®) Combo and Certifect(®) against Dipylidium caninum infestation of cats and dogs using a natural flea (Ctenocephalides felis) infestation model
por: Beugnet, Frederic, et al.
Publicado: (2013)

Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®
por: Abbate, Jessica M., et al.
Publicado: (2018)

Assessment of the prophylactic speed of kill of Frontline Tri-Act(®) against ticks (Ixodes ricinus and Rhipicephalus sanguineus) on dogs
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Sustained speed of kill and repellency of a novel combination of fipronil and permethrin against Ctenocephalides canis flea infestations in dogs
por: Beugnet, Frederic, et al.
Publicado: (2015)

Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs
por: Perier, Nadège, et al.
Publicado: (2019)

Knock-down and speed of kill of a combination of fipronil and permethrin for the prevention of Ctenocephalides felis flea infestation in dogs
por: Halos, Lénaïg, et al.
Publicado: (2016)

Experimental assessment of permethrin-fipronil combination in preventing Leishmania infantum transmission to dogs under natural exposures
por: Papadopoulos, Elias, et al.
Publicado: (2020)

Comparative efficacy on dogs of a single topical treatment with the pioneer fipronil/(S)-methoprene and an oral treatment with spinosad against Ctenocephalides felis
por: Beugnet, F., et al.
Publicado: (2011)

Analysis of Dipylidium caninum tapeworms from dogs and cats, or their respective fleas: Part 1. Molecular characterization of Dipylidium caninum: genetic analysis supporting two distinct species adapted to dogs and cats
por: Labuschagne, Michel, et al.
Publicado: (2018)

Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard(®)
por: Liebenberg, Julian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_782um95qr22s7mfeen3naj8ods